CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

NEWS & EVENTS

OXON Exhibiting at ISPOR Europe 2026

Generating RWE for Better Healthcare Decisions: OXON at ISPOR Europe 2026 8–11 November 2026 | Austria Center Vienna, Austria | Booth #831 How can real-world data provide the evidence needed to assess the value, effectiveness and safety of healthcare interventions? This question is central to the work of OXON Epidemiology, which will be exhibiting at…
Read more

Advancing Rare Disease Research at WODC Europe 2026

Advancing evidence generation for rare diseases and orphan drug development 27–29 October 2026 | RAI Amsterdam, The Netherlands OXON Epidemiology will be attending World Orphan Drug Congress Europe 2026, a leading international event bringing together pharmaceutical and biotechnology companies, researchers, patient organisations and other stakeholders to advance rare disease research and orphan drug development. Rare…
Read more

OXON AT ESMO CONGRESS 2026

OXON Epidemiology at ESMO Congress 2026: From Real-World Data to Reliable Evidence 23–27 October 2026 | IFEMA Madrid, Spain | Booth #8085, Hall 8 OXON Epidemiology will be exhibiting at ESMO Congress 2026, one of the leading international events in oncology, taking place in Madrid from 23 to 27 October. As advances in cancer treatment…
Read more

OXON’s RWE at ISPE 42nd Annual Meeting

OXON Epidemiology to Exhibit at the ISPE Annual Meeting 2026 29 August – 2 September 2026 | Allianz MiCo Convention Centre | Milan, Italy As an international contract research organisation (CRO) specialising in Real-World Evidence, pharmacoepidemiology and late-phase research, OXON Epidemiology is pleased to announce its participation as an exhibitor at the 42nd International Society…
Read more

Live Webinar on Real-World Pharmacovigilance in Clinical Practice

Real-World Pharmacovigilance with OXON and SafeMed: “Accelerating approval through real-time patient safety & drug monitoring” Webinar Details Date: 26 February 2026Time: 5pm CET | 4pm UK | 11am EST | 8am PSTDuration: 90 minutesPlatform: GoToWebinarOn 26 February 2026, OXON Epidemiology, in collaboration with SafeMed, will host a live expert-led webinar focused on real-world pharmacovigilance and…
Read more

19CTSS

Join OXON at the 19 CTSS in Munich in May

Advancing Clinical Innovation with OXON at 19CTSS May 21-22, 2025 | Munich OXON will support the summit showcasing expanded services and new developments in RWE.  We are proud to participate as a Silver Sponsor and exhibitor at the 19th Clinical Trials Strategic Summit (CTSS), taking place in Munich on May 21–22, 2025.  This year’s Clinical…
Read more

Join us at the Annual Clinical Outsourcing Summit (COS 2025) in Barcelona

Explore Cutting-Edge Clinical Trials and RWE Solutions with OXON at COS 2025 April 3-4, 2025 | Barcelona OXON will support as an exhibitor, showcasing expanded services and new developments in RWE.  Join OXON at booth E1 during the Annual Clinical Outsourcing Summit (COS 2025) on April 3rd and 4th in Barcelona. This event, themed “Driving…
Read more

FREE LIVE ONLINE WEBINAR SERIES ON RWE 2024-2025: RMMs Studies

‘Unlocking Success: Mastering your Real-World RMM Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON   Date: Thursday, 13 March 2025 Time: 5pm CEST | 11am EDT | 8am PST  Speaker: Prof. Antoine Pariente Director of the Department of Public Health & of the BPH AHeaD team – University of…
Read more

Genitourinary Cancers

White Paper: Breakthroughs in Genitourinary Cancers – Insights from ESMO 2024

Breakthroughs in Genitourinary Cancers – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The 2024 European Society for Medical Oncology Congress in Barcelona, ESMO 2024, served as a pivotal platform for unveiling breakthroughs and addressing ongoing challenges in Genitourinary Cancers.  This white paper dives deep into the transformative potential of…
Read more

White Paper: Breakthroughs in Prostate Cancer – Insights from ESMO 2024

Breakthroughs in Prostate Cancer – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The 2024 European Society for Medical Oncology Congress in Barcelona, ESMO 2024, served as a pivotal platform for unveiling breakthroughs and addressing ongoing challenges in prostate cancer care and research. Prostate cancer took center stage, with sessions…
Read more